Iridex (IRIX) Cash from Discontinued Operations (2011 - 2012)
Iridex (IRIX) posted Cash from Discontinued Operations of $148000.0 for Q4 2012, up 4.23% on a QoQ basis from $142000.0 in Q3 2012, and down 16.38% year-over-year from $177000.0 in Q4 2011.
Powered by 
Analysis
Iridex (IRIX) Cash from Discontinued Operations (2011 - 2012) Analysis & Trends
Iridex has reported Cash from Discontinued Operations for 2 years, with the latest figure at $148000.0 in Q4 2012.
- On a quarterly basis, Cash from Discontinued Operations fell 16.38% year-over-year to $148000.0 in Q4 2012; TTM through Sep 2013 was $148000.0, a 79.56% decrease from a year earlier, with the FY2012 full-year figure at $695000.0, down 12.8% from the prior year.
- Cash from Discontinued Operations was $148000.0 for Q4 2012 at Iridex, up from $142000.0 in the prior quarter.
- The five-year high for Cash from Discontinued Operations was $836000.0 in Q2 2011, with the low at -$264000.0 in Q3 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | - |
| 10 | Iridex | 12.22 Mn | 7.54 Mn | 4.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 29, 2012 | 148,000.00 |
| Sep 29, 2012 | 142,000.00 |
| Jun 30, 2012 | 604,000.00 |
| Mar 31, 2012 | -199,000.00 |
| Dec 31, 2011 | 177,000.00 |
| Oct 1, 2011 | 48,000.00 |
| Jul 2, 2011 | -264,000.00 |
| Apr 2, 2011 | 836,000.00 |